A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-0895|31|3|295-306

ISSN: 1520-7552

Source: DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.31, Iss.3, 2015-03, pp. : 295-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content